Drug profile · INN
dapagliflozin + metformin
XIGDUO XR 5/1000
dapagliflozin + metformin (XIGDUO XR 5/1000) is an FDA-listed pharmaceutical active ingredient. Associated with AstraZeneca.
TGA: approved
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — dapagliflozin + metformin
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.81
Quick answer
dapagliflozin + metformin (XIGDUO XR 5/1000) is an FDA-listed pharmaceutical active ingredient. Associated with AstraZeneca.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is dapagliflozin + metformin?
dapagliflozin + metformin (XIGDUO XR 5/1000) is an FDA-listed pharmaceutical active ingredient. Associated with AstraZeneca.
What is the brand name for dapagliflozin + metformin?
XIGDUO XR 5/1000 is a marketed brand name for dapagliflozin + metformin. Check FDA Drugs@FDA for the current US label holder and prescribing information.